Published in
Wiley, Alimentary Pharmacology and Therapeutics, 3(56), p. 463-476, 2022
DOI: 10.1111/apt.16937
Links
Tools
Real‐world multicentre observational study including population pharmacokinetic modelling to evaluate the exposure–response relationship of vedolizumab in inflammatory bowel disease: ERELATE Study
Journal article published in 2022 by
Niels Vande Casteele,
Niels Vande Casteele 
,
William J. Sandborn ,
Brian G. Feagan ,
Séverine Vermeire,
Parambir S. Dulai,
Andres Yarur,
Xavier Roblin ,
Shomron Ben‐Horin,
Iris Dotan,
Mark T. Osterman,
Maria Rosario,
Teresa McRorie Osborn,
Julian Panes,
Dirk Lindner
and other authors.
,
William J. Sandborn ,
Brian G. Feagan ,
Séverine Vermeire,
Parambir S. Dulai,
Andres Yarur,
Xavier Roblin ,
Shomron Ben‐Horin,
Iris Dotan,
Mark T. Osterman,
Maria Rosario,
Teresa McRorie Osborn,
Julian Panes,
Dirk Lindner
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 